- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Patent holdings for IPC class C07D 405/14
Total number of patents in this class: 10282
10-year publication summary
|
792
|
772
|
742
|
774
|
887
|
924
|
916
|
922
|
1043
|
282
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17205 |
252 |
| Merck Patent GmbH | 5909 |
218 |
| Bristol-myers Squibb Company | 5080 |
190 |
| Boehringer Ingelheim International GmbH | 4629 |
181 |
| Janssen Pharmaceutica N.V. | 3839 |
173 |
| Novartis AG | 11238 |
159 |
| Vertex Pharmaceuticals Incorporated | 1581 |
142 |
| Takeda Pharmaceutical Company Limited | 2961 |
141 |
| Merck Sharp & Dohme LLC | 3689 |
141 |
| Pfizer Inc. | 3322 |
123 |
| Gilead Sciences, Inc. | 1879 |
117 |
| F. Hoffmann-La Roche AG | 7958 |
115 |
| Idemitsu Kosan Co., Ltd. | 3995 |
106 |
| LT Materials Co., Ltd. | 312 |
104 |
| Genentech, Inc. | 3742 |
85 |
| Samsung SDI Co., Ltd. | 6671 |
77 |
| Samsung Display Co., Ltd. | 30585 |
70 |
| Amgen Inc. | 3779 |
69 |
| Epizyme, Inc. | 383 |
69 |
| Vanderbilt University | 1731 |
69 |
| Other owners | 7681 |